Market capitalization | $518.42m |
Enterprise Value | $495.49m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 1.64 |
P/S ratio (TTM) P/S ratio | 1.72 |
P/B ratio (TTM) P/B ratio | 1.46 |
Revenue growth (TTM) Revenue growth | 4.15% |
Revenue (TTM) Revenue | $302.06m |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
15 Analysts have issued a Health Catalyst Inc forecast:
15 Analysts have issued a Health Catalyst Inc forecast:
Sep '24 |
+/-
%
|
||
Revenue | 302 302 |
4%
4%
|
|
Gross Profit | 98 98 |
8%
8%
|
|
EBITDA | -20 -20 |
59%
59%
|
EBIT (Operating Income) EBIT | -63 -63 |
34%
34%
|
Net Profit | -79 -79 |
36%
36%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in Salt Lake City, UT.
Head office | United States |
CEO | Daniel Burton |
Employees | 1,300 |
Founded | 2008 |
Website | www.healthcatalyst.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.